CLINICAL_TRIALS
trial_result
· 2013-12-19
Clinical Trial Update: Gemtuzumab in Treating Patients With Myelodysplastic Syndrome [Phase 2]
Summary
This update reports on a Phase 2 clinical trial evaluating gemtuzumab ozogamicin for myelodysplastic syndromes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: UNKNOWN